Antibacterial agent 219
Antibacterial agent 219 (Compound 2/75c) exhibits antibacterial activity by targeting cell wall biosynthesis. Antibacterial agent 219 inhibits methicillin-resistant Staphylococcus aureus (MRSA) strains (MIC=0.5-32 µg/mL), Enterococcus faecium (MIC=2 µg/mL) and S. aureus (MIC=2 µg/mL) [1][2].
Product Specifications
CAS Number
[1649473-91-5]
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/antibacterial-agent-219.html
Smiles
FC1=CC=C(C=C1)OC2=CC=C(C3=NOC(C4=CC5=C(NC=C5)C=C4)=N3)C=C2
Molecular Formula
C22H14FN3O2
Molecular Weight
371.36
References & Citations
[1]Ceballos S, et al., Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria. Antimicrob Agents Chemother. 2018 Jul 27;62 (8) :e00453-18.|[2]Chang M, et al., Non-beta lactam antibiotics. WO2016049586.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![(5α,16β) -N-Acetyl-16-[2- (acetyloxy) acetyloxy) -2'H-androst-2-eno[3,2-c]pyrazol-17-one](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
001174 10 mg
(5α,16β) -N-Acetyl-16-[2- (acetyloxy) acetyloxy) -2'H-androst-2-eno[3,2-c]pyrazol-17-one
Ask
View Details 
MBS1346732-01 0.02 mg (E-Coli)
Recombinant Shigella sonnei Uncharacterized Nudix hydrolase NudL (nudL)
Ask
View Details